Aktuellt
SENASTE
Redeye endorses ISAB receiving positive feedback from the FDA regarding its white paper proposal submitted in January this year. An approval, which can happen by the end of Q3 or in the beginning of Q4 this year, would result in ISAB receiving annual funding of up to USD 0.25m for two years.
LÄS MER
